Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

BMC Cancer201212:549

DOI: 10.1186/1471-2407-12-549

Received: 7 June 2012

Accepted: 18 October 2012

Published: 23 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
7 Jun 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
8 Jun 2012 Author responded Author comments - Xiufen Zhuang
Resubmission - Version 4
8 Jun 2012 Submitted Manuscript version 4
2 Jul 2012 Reviewed Reviewer Report - Samuel Rabkin
7 Jul 2012 Reviewed Reviewer Report - Ya-Fang Mei
20 Jul 2012 Reviewed Reviewer Report - Faris Farassati
5 Aug 2012 Author responded Author comments - Xiufen Zhuang
Resubmission - Version 5
5 Aug 2012 Submitted Manuscript version 5
17 Aug 2012 Author responded Author comments - Xiufen Zhuang
Resubmission - Version 6
17 Aug 2012 Submitted Manuscript version 6
Publishing
18 Oct 2012 Editorially accepted
23 Nov 2012 Article published 10.1186/1471-2407-12-549

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Immunology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
(2)
Department of Urologic Surgery, Beijing Anzhen Hospital, Capital Medical University
(3)
Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University
(4)
Tianjin International Joint Academy of Biotechnology & Medicine

Advertisement